If you decide to receive GLP-1 medications in Arlington, consult with our team to discuss which one suits your goals
Although tirzepatide demonstrates greater efficacy in trials, transitions may be warranted, owing to intolerance, availability or formulary restrictions
In the Midwest, nearly 36% of people are obese, while nearly 35% of people in the South are obese
Here, the TV personality and fashion expert shares more about his personal experience with obesity, why the campaign is important and what's next in his life as his final chapter of Queer Eye comes to a close
MeAgain gives that view in one place with five food logging methods, symptom tracking, the shot log, and a weight trend that is easier to read than a string of daily numbers
The total number of lawsuits against glucagon-like peptide-1 (GLP-1) drug manufacturers, such as Novo Nordisk, has grown to nearly 2,200, with more cases being filed monthly